Age-related macular degeneration is a common eye condition causing central vision loss, mostly affecting adults over 50.

TOP INSIGHT
Ever wonder how we could revolutionize #AMD treatment? Scientists unveiled a brand new surgical technique allowing us to test two different grafts in the same lesion. #eyedisorders #stemcells vision_loss
Restoring Sight: Stem Cell Grafts for AMD
In diseases such as AMD, the light-sensitive retina tissue at the back of the eye degenerates. Scientists are testing therapies for restoring damaged retinas with grafts of tissue grown in the lab from patient-derived stem cells.Until now, surgeons have only been able to place one graft in the retina, limiting the area that can be treated in patients, and as well as the ability to conduct side-by-side comparisons in animal models. Such comparisons are crucial for confirming that the tissue grafts are integrating with the retina and the underlying blood supply from a network of tiny blood vessels known as the choriocapillaris.
For the technique, investigators designed a new surgical clamp that maintains eye pressure during the insertion of two tissue patches in immediate succession while minimizing damage to the surrounding tissue.
One graft consisted of retinal pigment epithelial (RPE) cells grown on a biodegradable scaffold. RPE cells support and nourish the retina’s light-sensing photoreceptors. In AMD, vision loss occurs alongside the loss of RPE cells and photoreceptors. In the lab, RPE cells are grown from human blood cells after they’ve been converted into stem cells. The second graft consisted of just the biodegradable scaffold to serve as a control.
Source-Eurekalert
MEDINDIA




Email




